Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Chiron Real Estate Inc. XRN

Insider Buys alert about insiders buying in the last 12 month

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.

Insider Decisions

Total buys
3.95
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy 2 1 9 7
Sell
Insider Ownership
9.71%

Capital & Financial Ratios

Market Cap
523.40
Revenue
153.43
Net Income
62.73
Free Cash Flow
37.56
Net Debt
622.39
Current Ratio
0.59
Debt/Equity
0.93
P/E ratio
9.65
P/S ratio
3.10
P/B ratio
1.02
Past 5Y EPS Growth
(34.34%)
This Y EPS Growth
399.27%
Next Y EPS Growth
(156.30%)
Next 5Y EPS Growth
16.23%
in millions of $

Dividends

Payout Ratio
2.63
Annual Dividend Rate
0.84
Annual Dividend Yield
8.84%
total individual payouts
2028 ‡‡‡‡
2027 ‡‡‡‡‡
2026 2.30
2025 3.30
2024 4.20
2023 4.20
2022 4.20
2021 5.13
2020 4.00
2019 4.00
2018 4.00
2017 4.20
2016 3.53
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 6.72 8.94 11.89 12.92
Receivables
Inventory
Other
6.72 8.94 11.89 12.92
2023 2024 2025 Q'26
Payables 12.78 16.47 18.29 20.97
ST’ Debt
Other
38.68 30.87 19.44 22.07
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡ ‡‡‡ ‡‡‡
Book Value ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 38.06 39.75
’25 34.62 37.97 37.23 38.39
148.21
’24 35.12 34.24 34.26 35.16
138.78
’23 36.23 36.35 35.51 32.96
141.05
’22 31.88 33.70 35.41 36.31
137.28
’21 27.35 28.26 29.98 30.34
115.94
’20 21.65 22.06 25.10 24.93
93.73
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 13.35 22.56
’25 12.27 22.14 17.57 21.63
73.61
’24 14.29 18.93 16.30 20.52
70.05
’23 15.77 17.88 16.67 18.13
68.44
’22 16.44 23.48 18.31 18.31
76.54
’21 15.29 17.79 18.61 17.28
68.97
’20 12.26 11.61 (5.48) 16.13
34.52
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 11.21 (20.05)
’25 (14.53) (16.99) 17.87 28.53
14.88
’24 12.29 23.26 (8.05) 4.79
32.30
’23 19.14 80.14 22.75 15.29
137.31
’22 (8.59) (52.92) (16.63) 16.36
(61.77)
’21 (28.46) (55.29) (31.93) (11.53)
(127.21)
’20 (56.41) 3.88 (66.31) (65.43)
(184.27)
in millions of $

EPS

Mar Jun Sep Dec Year
’26 (0.06) 4.78
’25 0.15 (0.05) (0.45) (0.55)
(0.91)
’24 0.05 (0.25) 0.15 0.10
0.05
’23 0.05 0.90 0.25 (0.05)
1.15
’22 0.20 0.15 0.60 0.05
1.00
’21 0.15 0.20 0.30 0.30
0.95
’20 0.15 0.00 (1.10) 0.10
(0.85)

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

2.3
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 35.05 40.20 37.15 29.05
Low Price
‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ 92.55 58.95 55.60 45.75
High Price
‡‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡ ‡‡‡‡ 29 26 26 30
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.73 5.42 5.34 4.94
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 137.28 141.05 138.78 148.21 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 100.00% 100.00% 100.00% 100.00%
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 20.00 21.73 6.69 (6.88)
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 14.57% 15.41% 4.82% (4.64%) ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 20.00 21.73 6.69 (6.88) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 59.86 61.39 58.33 61.68
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10.49 10.76 10.52 11.08 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡ 1.00 1.15 0.05 (0.91) ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.85 5.22 5.31 5.50
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (10.56) 5.25 (2.86) (4.39) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (4.72) 10.47 2.45 1.11
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 49.58 46.21 42.16 39.62
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 13.09 13.11 13.19 13.38 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ 47.05 47.83 772.00 0.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.49 5.11 3.67 3.05 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.07 1.36 1.06 1.11 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.06 9.24 8.18 7.39 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (20.15) 9.49 35.15 73.65
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 76.54 68.44 70.05 73.61 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (138.31) 68.87 (37.75) (58.73)
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (61.77) 137.31 32.30 14.88
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (57.04) (31.96) (21.92) (7.55)
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 642.91 589.02 635.06 656.12
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 628.45 582.30 626.11 644.23
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 649.07 605.81 555.92 530.07
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ 1.00% 1.11% 0.06% (0.97%)
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.88% 2.00% 1.74% 1.95%
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.34% 2.68% 0.16% (2.73%)
ROE
predictions in italic, sparklines do not include predictions

Chiron Real Estate Inc. (XRN) Latest News

News by impact score

Fine-tune

12 Sep

4 , 6:28 AM
Chiron Real Estate Inc. (XRN) has turned its second quarter results into a strategic pivot point for future operations and positioning. Q2 performance marks a strategic pivot likely to shift company trajectory and investor views.

12 Aug

3 transcript www.fool.com, 8:13 PM
Chiron Real Estate Inc. (XRN) released its Q2 2026 earnings call transcript. Quarterly earnings calls disclose financial results and outlook that can move stock prices in the near term.

5 Aug

4 , 4:07 PM
Global Medical REIT Inc. (GMRE) reported its financial results for the second quarter of 2025, highlighting key metrics such as revenue growth and net income. The company continues to expand its portfolio of healthcare-related properties, which has contributed to its overall performance. Management expressed optimism about future growth prospects and strategic initiatives aimed at enhancing shareholder value. Significant revenue growth and strategic portfolio expansion are likely to impact future performance positively.

3 , 4:05 PM
Chiron Real Estate Inc. (XRN) announced its second quarter 2026 financial results. Quarterly earnings releases deliver core financial data that can shift near-term stock valuation and sentiment.

3 , 5:50 PM
Global Medical REIT Inc. (GMRE) reported its Q2 funds from operations (FFO), meeting analysts' estimates. The company continues to focus on acquiring and managing healthcare-related real estate, contributing to its stable financial performance. GMRE's portfolio remains diversified, with a strong emphasis on properties leased to healthcare providers. The results reflect the company's ongoing strategy to enhance shareholder value through strategic acquisitions and effective management of its assets. The FFO meeting estimates indicates stable financial performance, but does not signal a significant change in trajectory.

3 Associated Press Finance, 4:48 PM
Global Medical REIT Inc. reported its Q2 earnings, highlighting key financial metrics and operational updates. The company continues to focus on expanding its portfolio of healthcare facilities, which has shown resilience amid market fluctuations. Management provided insights into future growth strategies and the overall performance of their properties, indicating a positive outlook despite challenges in the broader economic environment. The earnings report reflects moderately noticeable influences on financial performance and growth strategies.

2 Jul

3 , 2:13 PM
Chiron Real Estate (XRN) stock sees fair value cut as analysts split on portfolio shift. Fair value cut and analyst split on portfolio shift point to moderate effects on XRN market perception and trajectory.

30 Jun

4 , 9:22 AM
Chiron Real Estate Inc. (XRN) accelerates portfolio transition via recapitalization of IRF assets. Recapitalization of IRF assets marks a major strategic portfolio shift that can significantly alter company trajectory.

1 Jun

4 Business Wire, 5:00 PM
Chiron Real Estate Inc. (XRN) completed acquisition of inaugural SHOP Communities. Completion of first SHOP Communities acquisition marks major strategic expansion likely to alter company trajectory.

8 May

4 transcript www.fool.com, 12:59 PM
Chiron Real Estate Inc. (XRN) released the transcript of its Q1 2026 earnings call, detailing quarterly financial results, operational updates, and management's outlook. Q1 earnings call transcripts disclose financial performance, strategic initiatives, and guidance that significantly influence investor sentiment and stock trajectory.

6 May

4 Business Wire, 4:06 PM
Chiron Real Estate Inc. (XRN) announced a $100 million strategic convertible perpetual preferred equity investment led by Maewyn Capital Partners. $100 million strategic investment bolsters Chiron Real Estate Inc.'s capital for expansion and signals strong investor confidence, significantly enhancing future growth and market performance.

4 Business Wire, 4:06 PM
Chiron Real Estate Inc. (XRN) enters into agreements to acquire $425 million of SHOP communities. The $425 million acquisition of SHOP communities marks a major strategic expansion of Chiron's real estate portfolio, likely boosting assets and future performance.

3 Business Wire, 4:05 PM
Chiron Real Estate Inc. (XRN) announced first quarter 2026 financial results. Quarterly financial results provide key insights into operational performance and influence investor sentiment moderately.

25 Feb

4 Associated Press Finance, 4:48 PM
Global Medical REIT Inc. (XRN) released its Q4 earnings snapshot, detailing financial results for the quarter. Q4 earnings snapshots reveal key financial metrics that significantly influence REIT stock performance and investor sentiment.

3 Business Wire, 4:05 PM
Chiron Real Estate Inc. announced fourth quarter and full-year 2025 financial results. Financial results for Q4 and full-year 2025 provide key data on Global Medical REIT Inc.'s (XRN) performance, occupancy, revenue, and outlook.

6 Feb

3 Simply Wall St., 6:39 AM
Global Medical REIT Inc. (GMRE) is highlighted as an undervalued small-cap stock with notable insider buying activity. The article suggests that such insider actions may indicate confidence in the company's future performance. Investors are encouraged to consider GMRE as a potential opportunity in February 2026, given the current market conditions and the company's positioning within the healthcare real estate sector. Insider buying activity may influence market sentiment and investor interest, but the overall impact on GMRE's trajectory is expected to be limited.

3 Feb

3 Business Wire, 8:00 AM
Global Medical REIT Inc. has announced a strategic rebranding to Chiron Real Estate Inc. as part of its efforts to enhance its identity and market presence. The rebrand aims to better reflect the company's focus on healthcare real estate investments and align with its long-term growth strategy. Management believes this change will strengthen relationships with stakeholders and improve overall brand recognition in the healthcare sector. Rebranding may moderately influence market perception and stakeholder relationships, but its overall impact on financial performance is expected to be limited.

31 Dec

4 Simply Wall St., 6:39 AM
Global Medical REIT Inc. (GMRE) is highlighted as an undervalued small-cap stock with notable insider interest in December 2025. The article emphasizes the potential for growth in GMRE, driven by strategic investments and market positioning within the healthcare real estate sector. Insider buying suggests confidence in the company's future performance, making it an attractive option for investors seeking undervalued opportunities. Insider interest indicates strong confidence in GMRE's future, suggesting significant potential for market performance.

13 Nov

3 Business Wire, 10:30 PM
Global Medical REIT Inc. has announced the pricing of its public offering of 8.00% Series B Preferred Stock. The offering is expected to raise approximately $50 million, with the proceeds intended for general corporate purposes, including potential acquisitions of healthcare-related properties. The preferred stock is set to be listed on the New York Stock Exchange under the ticker symbol 'GMRE.PRB'. The public offering of preferred stock may provide additional capital for acquisitions, impacting financial performance moderately.

3 Business Wire, 8:39 AM
Global Medical REIT Inc. has announced a proposed public offering of its Series B Preferred Stock. The offering aims to raise capital to support the company's growth initiatives and enhance its financial flexibility. Specific terms of the offering, including the number of shares and pricing, have not yet been disclosed. The company intends to use the proceeds for general corporate purposes, which may include funding acquisitions and other investments. The proposed offering could moderately influence GMRE's financial performance and market sentiment, depending on the terms and investor reception.

5 Nov

4 transcript GuruFocus.com, 6:02 PM
Global Medical REIT Inc. (GMRE) reported its Q3 2025 earnings, highlighting strategic initiatives aimed at enhancing its market position. The company discussed its ongoing investments in healthcare real estate and outlined plans for future acquisitions to drive growth. Management emphasized the importance of adapting to market trends and maintaining a strong portfolio to meet investor expectations. Overall, the earnings call reflected a commitment to long-term value creation amidst evolving industry dynamics. Strategic initiatives and future acquisitions are likely to significantly impact GMRE's market position and investor sentiment.

3 Simply Wall St., 9:14 PM
Global Medical REIT Inc. reported a profit driven by a one-off gain, raising concerns about the quality of its earnings and the sustainability of its dividend. Analysts are questioning whether the profit reflects the company's ongoing operational performance or is merely an anomaly. This situation has sparked discussions among investors regarding the reliability of GMRE's financial health and future dividend payouts. The one-off gain raises questions about earnings quality, which could moderately influence investor sentiment and financial performance.

4 Nov

4 Associated Press Finance, 5:49 PM
Global Medical REIT Inc. (GMRE) reported its Q3 earnings, showcasing a revenue increase driven by strategic acquisitions and a growing portfolio of medical facilities. The company highlighted its commitment to expanding its footprint in the healthcare real estate sector, with a focus on long-term leases and stable tenants. Despite challenges in the broader market, GMRE's performance reflects resilience and a solid operational strategy aimed at enhancing shareholder value. The earnings report indicates significant growth and strategic moves that could alter the company's trajectory and investor sentiment.

4 Business WireGuruFocus.comMT NewswiresGuruFocus.comZacksZacksGuruFocus.comGuruFocus.com, 4:05 PM
Global Medical REIT Inc. (GMRE) reported its financial results for the third quarter of 2025, highlighting key metrics such as revenue growth and net income. The company continues to expand its portfolio of healthcare facilities, contributing to its overall performance. Management expressed optimism about future growth prospects and strategic initiatives aimed at enhancing shareholder value. Significant growth in revenue and strategic portfolio expansion are likely to impact future performance positively.

8 Oct

4 Business WireMT Newswires, 4:05 PM
Global Medical REIT Inc. has amended and restated its credit facility, enhancing its financial flexibility and liquidity. The updated terms include an increase in the borrowing capacity and an extension of the maturity date. This move is expected to support the company's growth strategy and operational needs, allowing for potential acquisitions and investments in medical real estate. The amendment of the credit facility significantly enhances financial flexibility, which is crucial for future growth and investment opportunities.

19 Sep

3 Business Wire, 5:00 PM
Global Medical REIT Inc. has completed a one-for-five reverse stock split, reducing the number of its outstanding shares. This move aims to increase the stock price and improve its appeal to institutional investors. The reverse split will adjust the company's share price accordingly, with shareholders receiving one new share for every five shares they previously owned. The company believes this action will enhance its market position and facilitate future growth. The reverse stock split may influence market sentiment and the company's stock price, but its overall impact on long-term performance is expected to be limited.

3 Sep

3 Business Wire, 4:05 PM
Global Medical REIT Inc. has announced the declaration of common and preferred dividends for the third quarter of 2025. The board's decision reflects the company's ongoing commitment to returning value to shareholders. Details regarding the dividend amounts and payment dates were provided, indicating a stable financial position and continued operational performance. The dividend declaration indicates financial stability but does not significantly alter the company's overall trajectory.

13 Aug

3 , 4:15 PM
Global Medical REIT Inc. has announced a $50 million common stock repurchase program alongside a one-for-five reverse stock split. The repurchase program aims to enhance shareholder value, while the reverse split is intended to increase the stock price and attract institutional investors. Both measures are part of the company's strategy to improve its market position. The stock repurchase program and reverse split may influence market sentiment and financial performance but are not expected to fundamentally alter the company's trajectory.

23 Jun

3 , 7:00 AM
Global Medical REIT Inc. has appointed Mark Decker, Jr. as its new Chief Executive Officer, effective immediately. Decker brings over 20 years of experience in the healthcare real estate sector and has previously held leadership roles at various companies. His appointment is expected to enhance the company's strategic direction and operational efficiency. Leadership changes can moderately influence company performance and market sentiment.

9 May

3 GuruFocus.com, 3:24 AM
Global Medical REIT Inc. (GMRE) reported a portfolio occupancy rate of 95.6% and net income of $2.1 million for Q1 2025. The company completed a $69.6 million acquisition of five properties and sold two medical properties for $8.2 million. However, total revenues decreased by 1.4% to $34.6 million, and the company faced challenges with Prospect Medical Group's bankruptcy affecting lease payments. Retention rates for expiring leases were lower than expected at 62%, and leverage increased to 46.1%. A new CEO is expected by June 30, 2025. The mixed financial performance and strategic acquisitions indicate a moderately noticeable influence on GMRE's future.

© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us